HBCo — Hofseth Biocare ASA Balance Sheet
0.000.00%
- NOK832.81m
- NOK977.42m
- NOK257.42m
Annual balance sheet for Hofseth Biocare ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 171 | 47.2 | 29.9 | 20.9 | 25.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 14.3 | 10.1 | 14.1 | 14.8 | 18.9 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 271 | 170 | 176 | 131 | 112 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 138 | 186 | 169 | 166 | 138 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 459 | 416 | 411 | 390 | 341 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 106 | 151 | 172 | 252 | 168 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 195 | 275 | 262 | 348 | 279 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 264 | 141 | 149 | 41.8 | 62 |
Total Liabilities & Shareholders' Equity | 459 | 416 | 411 | 390 | 341 |
Total Common Shares Outstanding |